This information was published on 2025-05-19T08:13:26 for IP Right Registration Published.
| Field | Value |
| (210) | 2493724 (IR 1843907) |
| (220) |
25 Oct 2024
|
| (300) |
US, 09 Oct 2024, 98792313
|
| (511) (510) |
Class 3
Cosmetics Class 5 Pharmaceutical and veterinary products to maintain or enhance health or treat disease; antibiotics; pharmaceutical and veterinary products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical and veterinary products, ingredients and preparations, namely, pharmaceutical products and preparations for the impairment and prevention of infection, including planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; pharmaceutical and nutraceutical products for enhancing microbiome health; extracellular matrix and extracellular polymeric substances including polysaccharides, monosaccharides, exopolysaccharides, and proteins, being dietary supplements; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents; antimicrobial resistance breakers; human and animal antimicrobial treatments; pharmaceutical and veterinary products and preparations to prevent or mitigate bacterial biofilms and infections; cleaning agents and disinfectants for medical purposes, cleaning agents and disinfectants for hygiene purposes, cleaning agents and disinfectants for veterinary purposes, antimicrobial cleaning agents and disinfectants Class 31 Animal feed |
| (540) | LIXA |
| (550) | Word |
| (730) |
Neolixir Limited
ACN/ABN 58654969310 |
| (750) |
Bennett Litigation and Commercial Law
|
Find out more about publications on the About page.